Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "B.com Part II Results 2009 Private"

19:42 EDT 31st July 2014 | BioPortfolio

Matching Channels

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Lipitor

Lipitor was the best selling drug in 2009, with the 2009 annual sales coming in at over $5m for its company, Pfizer Inc. Lipitor is the brand name for an atorvastatin calcium medication that is pres...

The Asymptomatic Patient With Abnormal Laboratory Test Results

MatBA - Mature B-cell neoplasm array

Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genet...

Nexium

Nexium is the 2nd most profitable drug in 2009, according to 2009 annual sales figures, where it generated just over $5m in sales for its company, AstraZeneca Pharmaceuticals.  Nexium is a pr...

Matching News

LFB: M&A activity 2009 – 2014

LFB has announced only one M&A deal since 2009, with the acquisition of GTC TherapeuticsAbstracted from: Report: Partnering Agreements with LFB 2009-2014 LFB Group is not an active acquirer. In th...

The Problem with Greece

Greece’s economic crisis that started at the end of 2009 – which has increased unemployment from 10% (2009) to 27.5% (last quarter of 2013), and decreased GDP in millions of euros from 231.081 (20...

Actelion: M&A activity 2009-2014

Actelion has announced only 1 M&A deal since 2009, with the deal being the acquisition of Ceptaris Therapeutics.Abstracted from: Partnering Agreements with Actelion 2009-2014 Actelion is involved...

M&A Activity for Ipsen

Ipsen merger and acquisition deals during 2009-2014 in pharmaceuticals reviewed. Ipsen has announced only 1 M&A deal since 2009, with the acquisition of Syntaxin. Abstracted from: Partnering Agree...

United Therapeutics: M&A activity 2009-2014

United Therapeutics is a top big biotech company occupying the 18th spot at Current Partnering listed by 2012 sales revenues. United Therapeutics being a fairly small company has entered into only one...

Proposed CMS Rule Increases OIG and FCA Focus on Fraud on the Medicare Part D Prescription Drug Benefit

Ross Brooks and Inayat Ali Hemani | Sanford Heisler LLP The Medicare Part D Prescription Drug Benefit (“Part D”) has dramatically increased the role of private government contractors in the d...

Salary Survey Results

Nearly 1,200 speech and hearing professionals took our salary survey in the last quarter of 2013, sharing their salary range, title, education level and more. Now it's time to share the results in our...

Regeneron Pharmaceuticals: Partnering activity 2009-2014

Regeneron Pharmaceuticals announced around 18 partnering / licensing deals since 2009. Abstracted from: Partnering Agreements with Regeneron Pharmaceuticals 2009-2014The number of partnering, collabor...

Matching PubMed Articles

Teaching Basic Life Support to Students of Public and Private High Schools.

Background: Despite being recommended as a compulsory part of the school curriculum, the teaching of basic life support (BLS) has yet to be implemented in high schools in most countries. Objectives: T...

Analysis of barriers to the use of thrombolytics in ischemic stroke in a private hospital in Rio de Janeiro, Brazil.

Ischemic stroke is a major cause of neurological sequelae and death. The correct use of thrombolytic therapy faces several barriers. The objective was to discuss barriers to thrombolytic therapy in a...

Private Practice of Prosthodontists in the United States: Results from the 2008 & 2011 Surveys of Prosthodontists.

The purpose of this article is to review data and results from past surveys of prosthodontists sponsored and conducted by the American College of Prosthodontists. Surveys were conducted in 2002, 2005,...

Socioeconomic Disparities in Diagnostic Testing after Positive Aneuploidy Screening.

Objective The objective of this study was to investigate the association between type of health insurance (Medicaid vs. private) and uptake of diagnostic testing for fetal aneuploidy after a positiv...

Reflections on public-private participation in healthcare.

Health care is one of the major issues in social policy, affected by multiple factors, such as the increase in health costs, crisis, and the degree of private participation in the financing of service...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement